1. Home
  2. GOSS vs LAZR Comparison

GOSS vs LAZR Comparison

Compare GOSS & LAZR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GOSS
  • LAZR
  • Stock Information
  • Founded
  • GOSS 2015
  • LAZR 2012
  • Country
  • GOSS United States
  • LAZR United States
  • Employees
  • GOSS N/A
  • LAZR N/A
  • Industry
  • GOSS Biotechnology: Pharmaceutical Preparations
  • LAZR Auto Parts:O.E.M.
  • Sector
  • GOSS Health Care
  • LAZR Consumer Discretionary
  • Exchange
  • GOSS Nasdaq
  • LAZR Nasdaq
  • Market Cap
  • GOSS 237.9M
  • LAZR 246.4M
  • IPO Year
  • GOSS 2019
  • LAZR N/A
  • Fundamental
  • Price
  • GOSS $0.96
  • LAZR $6.72
  • Analyst Decision
  • GOSS Strong Buy
  • LAZR Hold
  • Analyst Count
  • GOSS 5
  • LAZR 9
  • Target Price
  • GOSS $9.20
  • LAZR $44.50
  • AVG Volume (30 Days)
  • GOSS 1.0M
  • LAZR 3.6M
  • Earning Date
  • GOSS 03-04-2025
  • LAZR 02-25-2025
  • Dividend Yield
  • GOSS N/A
  • LAZR N/A
  • EPS Growth
  • GOSS N/A
  • LAZR N/A
  • EPS
  • GOSS N/A
  • LAZR N/A
  • Revenue
  • GOSS $105,322,000.00
  • LAZR $75,025,000.00
  • Revenue This Year
  • GOSS N/A
  • LAZR $2.70
  • Revenue Next Year
  • GOSS N/A
  • LAZR $64.52
  • P/E Ratio
  • GOSS N/A
  • LAZR N/A
  • Revenue Growth
  • GOSS N/A
  • LAZR 27.61
  • 52 Week Low
  • GOSS $0.50
  • LAZR $4.93
  • 52 Week High
  • GOSS $1.60
  • LAZR $45.68
  • Technical
  • Relative Strength Index (RSI)
  • GOSS 54.23
  • LAZR 46.70
  • Support Level
  • GOSS $0.83
  • LAZR $5.73
  • Resistance Level
  • GOSS $1.18
  • LAZR $7.73
  • Average True Range (ATR)
  • GOSS 0.10
  • LAZR 1.03
  • MACD
  • GOSS -0.01
  • LAZR 0.20
  • Stochastic Oscillator
  • GOSS 41.37
  • LAZR 29.90

About GOSS Gossamer Bio Inc.

Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.

About LAZR Luminar Technologies Inc.

Luminar Technologies Inc is an automotive technology company ushering in a new era of vehicle safety and autonomy. It operates its business through the following segments: Autonomy Solutions and advanced Technologies and Services. The majority of revenue is earned from the Autonomy Solutions segment which engaged in the design, manufacturing, and sale of LiDAR sensors catering mainly to the OEMs in the automobile, commercial vehicle, robo-taxi, and adjacent industries and advanced Technologies and Services provides semiconductors and related components, as well as design, test and consulting services to the Autonomy Solutions segment and various third-party customers, including government agencies and defense contractors, in markets generally unrelated to autonomous vehicles.

Share on Social Networks: